Molecular Templates Inc (MTEM)
1.40
-0.08
(-5.41%)
USD |
NASDAQ |
May 13, 16:00
1.41
+0.01
(+0.71%)
After-Hours: 20:00
Molecular Templates Profit Margin (Quarterly): -59.47% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -59.47% |
| September 30, 2023 | -72.45% |
| June 30, 2023 | -164.0% |
| March 31, 2023 | 32.25% |
| December 31, 2022 | -844.5% |
| September 30, 2022 | -581.1% |
| June 30, 2022 | -552.9% |
| March 31, 2022 | -254.7% |
| December 31, 2021 | -57.02% |
| September 30, 2021 | -1.28K% |
| June 30, 2021 | -103.1% |
| March 31, 2021 | -831.6% |
| December 31, 2020 | -813.4% |
| September 30, 2020 | -540.4% |
| June 30, 2020 | -517.0% |
| March 31, 2020 | -1.22K% |
| December 31, 2019 | -338.8% |
| September 30, 2019 | -1.20K% |
| June 30, 2019 | -175.6% |
| March 31, 2019 | -96.18% |
| December 31, 2018 | -162.7% |
| September 30, 2018 | -258.2% |
| June 30, 2018 | -1.03K% |
| March 31, 2018 | -3.77K% |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | -1.69K% |
| June 30, 2017 | 38.17% |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | -174.8% |
| June 30, 2015 | -225.7% |
| March 31, 2015 | -303.0% |
| December 31, 2014 | -162.0% |
| September 30, 2014 | -210.5% |
| June 30, 2014 | -20.82% |
| March 31, 2014 | -193.1% |
| December 31, 2013 | -236.3% |
| September 30, 2013 | 36.97% |
| June 30, 2013 | -402.1% |
| March 31, 2013 | -315.3% |
| December 31, 2012 | |
| September 30, 2012 | -55.15% |
| June 30, 2012 | |
| March 31, 2012 | -45.85K% |
| December 31, 2011 | -8.51K% |
| September 30, 2011 |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-1.28K%
Minimum
Sep 2021
32.25%
Maximum
Mar 2023
-503.9%
Average
-517.0%
Median
Jun 2020
Profit Margin (Quarterly) Benchmarks
| AIM ImmunoTech Inc | -19.35K% |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | -57.64% |
| Electromed Inc | 10.76% |
| Armata Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -13.96% |
| Return on Invested Capital | -70.20% |
| Operating Margin (Quarterly) | -80.90% |
| Return on Net Operating Assets | -33.22% |